Kinetics and performance of the Abbott architect SARS-CoV-2 IgG antibody assay
Errataetall: |
CommentOn: J Infect. 2020 Aug;81(2):e39-e45. - PMID 32504735 |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:81 |
---|---|
Enthalten in: |
The Journal of infection - 81(2020), 6 vom: 01. Dez., Seite e7-e9 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Hamilton, Fergus [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 25.12.2020 Date Revised 29.03.2024 published: Print-Electronic CommentOn: J Infect. 2020 Aug;81(2):e39-e45. - PMID 32504735 Citation Status MEDLINE |
---|
doi: |
10.1016/j.jinf.2020.07.031 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM313149518 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM313149518 | ||
003 | DE-627 | ||
005 | 20240329233923.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.jinf.2020.07.031 |2 doi | |
028 | 5 | 2 | |a pubmed24n1354.xml |
035 | |a (DE-627)NLM313149518 | ||
035 | |a (NLM)32739487 | ||
035 | |a (PII)S0163-4453(20)30510-7 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Hamilton, Fergus |e verfasserin |4 aut | |
245 | 1 | 0 | |a Kinetics and performance of the Abbott architect SARS-CoV-2 IgG antibody assay |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 25.12.2020 | ||
500 | |a Date Revised 29.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a CommentOn: J Infect. 2020 Aug;81(2):e39-e45. - PMID 32504735 | ||
500 | |a Citation Status MEDLINE | ||
650 | 4 | |a Letter | |
650 | 4 | |a Comment | |
650 | 7 | |a Antibodies, Viral |2 NLM | |
650 | 7 | |a Immunoglobulin G |2 NLM | |
700 | 1 | |a Muir, Peter |e verfasserin |4 aut | |
700 | 1 | |a Attwood, Marie |e verfasserin |4 aut | |
700 | 1 | |a Vipond, Alan Noela Barry |e verfasserin |4 aut | |
700 | 1 | |a Hopes, Richard |e verfasserin |4 aut | |
700 | 1 | |a Moran, Ed |e verfasserin |4 aut | |
700 | 1 | |a Maskell, Nick |e verfasserin |4 aut | |
700 | 1 | |a Warwick, Deborah |e verfasserin |4 aut | |
700 | 1 | |a Albur, Mahableshwar |e verfasserin |4 aut | |
700 | 1 | |a Turner, Jonathan |e verfasserin |4 aut | |
700 | 1 | |a MacGowan, Alasdair |e verfasserin |4 aut | |
700 | 1 | |a Arnold, David |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The Journal of infection |d 1982 |g 81(2020), 6 vom: 01. Dez., Seite e7-e9 |w (DE-627)NLM012791822 |x 1532-2742 |7 nnns |
773 | 1 | 8 | |g volume:81 |g year:2020 |g number:6 |g day:01 |g month:12 |g pages:e7-e9 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jinf.2020.07.031 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 81 |j 2020 |e 6 |b 01 |c 12 |h e7-e9 |